Biomarkers predict the occurrence of BPSD
| Project/Area Number |
26461751
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Psychiatric science
|
|---|
| Research Institution | University of Miyazaki |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | 認知症 / バイオマーカー / BPSD / 介護負担 / 介護うつ / 唾液 / コルチゾール / メラトニン |
|---|
| Outline of Final Research Achievements |
Current Japan is super aged society, and a major problem to face is increase of the number of dementia. The cause that the patients are refused to be stayed at home is occurrence of BPSD. A cerebral pathologic change and the stress consisting of environmental factors influence BPSD. Therefore we must predict the occurrence of BPSD to care them immediately. This time, I could take in vivo biomarkers (cortisol, melatonin in saliva) and evaluate psychological symptoms and cognitive functions at the same time every three months for a year. Result: I knew that some apparent changes might occur when I checked each hormone level before big change of psychological symptoms appeared. Therefore, I thought that I might predict a symptom change by seeing changes of the biomarkers. I think that these methods lead to improvement of the quality of life of the patient and the reduction of the burden on caregiver.
|
Report
(4 results)
Research Products
(4 results)
